APPENDIX L - FDA CPIC BCE - RE-BASELINE TEMPLATE 2019-09.PDF
Published: 12/24/2019
Description
U.S. Food and Drug Administration 1 3WFN 11601 Landsdown St. North Bethesda, MD 2082 www.fda.gov Rebaseline Change Event (For FDA Investments) Introduction: As defined by OMB, acceptable reasons for a Rebaseline are: a. A significant cha...
